首页> 外文OA文献 >Long‐term treatment of older patients with overactive bladder using a combination of mirabegron and solifenacin: a prespecified analysis from the randomized, phase III SYNERGY II study

【2h】

Long‐term treatment of older patients with overactive bladder using a combination of mirabegron and solifenacin: a prespecified analysis from the randomized, phase III SYNERGY II study

机译：使用M拉释和Solifenacin的组合的长期治疗老年膀胱过度膀胱：随机，第III期Synergy II研究的预先分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Elizabeth R. Mueller; Rob van Maanen; Christopher Chapple; Paul Abrams; Sender Herschorn; Dudley Robinson; Matthias Stoelzel; Sang J. Yoon; Salman Al‐Shukri; Tomasz Rechberger; Christian Gratzke;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Long‐term treatment of older patients with overactive bladder using a combination of mirabegron and solifenacin: a prespecified analysis from the randomized, phase III SYNERGY II study [J] . Mueller Elizabeth R., van Maanen Rob, Chapple Christopher, Neurourology and urodynamics. . 2019,第2期

机译：使用M拉释和Solifenacin的组合的长期治疗较老膀胱过度膀胱的患者：来自随机，第III期Synergy II研究的预先分析
2. Long-term Safety and Efficacy of Mirabegron and Solifenacin in Combination Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (SYNERGY II) [J] . Gratzke Christian, van Maanen Rob, Chapple Christopher, European urology . 2018,第4期

机译：与膀胱过热膀胱患者的单一疗法相比，Mirabegron和Solifenacin的长期安全性和疗效组合：随机，多期第3研究（Synergy II）
3. Mirabegron for the treatment of overactive bladder: A prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies [J] . NittiV.W., KhullarV., VanKerrebroeckP., International journal of clinical practice . 2013,第7期

机译：M拉萨比格罗因治疗过度活跃的膀胱：三种随机，双盲，安慰剂控制，第三期研究的预先收集的汇集疗效分析和合并的安全性分析
4. Electrical Stimulation of the Transcutaneous Posterior Tibial Nerve for the Treatment of Patients with Detrusor Overactivity Due to Neurogenic Hiperactive Bladder in Multiple Sclerosis A Case Study [C] . Fabiana S. B. Perez, Luciana R. Tenorio Peixoto, Fabiano Soares, International Conference on Biomedical Electronics and Devices . 2014

机译：经皮后胫骨神经的电气刺激治疗多发性硬化中神经源性膀胱患者患者的患者案例研究
5. Recruitment, retention and compliance in randomized, phase III clinical trials involving obese patients diagnosed with type 2 Diabetes Mellitus with respect to weight loss practicum report. [D] . Mithani, Moez S. 2012

机译：涉及诊断为2型糖尿病的肥胖患者的有关减肥实践的随机III期临床试验中的招募，保留和依从性报告。
6. Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised double-blind placebo-controlled phase III studies [O] . V W Nitti, V Khullar, P Kerrebroeck, -1

机译：Mirabegron用于膀胱过度活动症的治疗：对三项随机双盲安慰剂对照的III期研究进行预先设定的合并疗效分析和合并安全性分析
7. Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies [O] . Nitti, V. W., Khullar, V., van Kerrebroeck, P., 2013

机译：Mirabegron用于膀胱过度活动症的治疗：对三项随机，双盲，安慰剂对照的三期研究进行预先设定的合并疗效分析和合并安全性分析

Long‐term treatment of older patients with overactive bladder using a combination of mirabegron and solifenacin: a prespecified analysis from the randomized, phase III SYNERGY II study

著录项

引文网络

相似文献

相关主题

期刊订阅